The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1975) · Medical Entomology and Zoology · Cited by 7,245
(1962) · Medical Entomology and Zoology · Cited by 4,856
Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association
Greenberg, D. B. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71896-4 · Cited by 222
Everybody has won, and all must have prizes
Patel, L. K., & David, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)06346-5 · Cited by 45
Modification of clozapine-induced leukopenia and neutropenia with lithium carbonate
Adityanjee (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.648 · Cited by 45
Cited by
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.441 · Cited by 2,343
Robinson, D., Woerner, M. G., Alvir, J. M. J., Bilder, R., Goldman, R., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.241 · Cited by 1,327
Mental health in elite athletes: International Olympic Committee consensus statement (2019)
Reardon, C. L., Hainline, B., Aron, C. M., Baron, D., Baum, A. L., Bindra, A., Budgett, R., Campriani, N., Castaldelli-Maia, J. M., Currie, A., et al. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2019-100715 · Cited by 1,277
DEPARTMENT OF HEALTH & HUMAN SERVICES
Schuchat, A. (2015) · Pharmacy Today · doi:10.1016/s1042-0991(15)32122-8 · Cited by 1,098
Geddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000) · BMJ · doi:10.1136/bmj.321.7273.1371 · Cited by 1,062
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Spector, A., Thorgrimsen, L., Woods, B., Royan, L., Davies, S., Butterworth, M., & Orrell, M. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.3.248 · Cited by 876
Leucht, S., Pitschel-Walz, G., Abraham, D., & Kissling, W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00105-4 · Cited by 796
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
Lehman, A. F., Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., Dixon, L. B., Goldberg, R., Green-Paden, L. D., Tenhula, W. N., Boerescu, D., Tek, C., et al. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007071 · Cited by 757
Leucht, S., Wahlbeck, K., Hamann, J., & Kissling, W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13306-5 · Cited by 725
Schizophrenia, substance abuse, and violent crime
Fazel, S. (2009) · JAMA · doi:10.1001/jama.2009.675 · Cited by 726
Sensky, T., Turkington, D., Kingdon, D., Scott, J. L., Scott, J., Siddle, R., O'Carroll, M., & Barnes, T. R. E. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.165 · Cited by 693
Singh, J. P., Grann, M., & Fazel, S. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.11.009 · Cited by 661
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Chakos, M., Lieberman, J., Hoffman, E., Bradford, D., & Sheitman, B. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.4.518 · Cited by 631
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
De Deyn, P. P., Rabheru, K., Rasmussen, A., Bocksberger, J. P., Dautzenberg, P. L. J., Eriksson, S., & Lawlor, B. A. (1999) · Neurology · doi:10.1212/wnl.53.5.946 · Cited by 615
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Adequacy of Treatment for Serious Mental Illness in the United States
Wang, P. S., Demler, O., & Kessler, R. C. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.1.92 · Cited by 581
Peer support among individuals with severe mental illness: A review of the evidence.
Davidson, L., Chinman, M., Kloos, B., Weingarten, R., Stayner, D., & Tebes, J. K. (1999) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.6.2.165 · Cited by 579
Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.19 · Cited by 567
Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s2 · Cited by 519
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp130 · Cited by 499
Implementing Evidence-Based Practices for Persons With Severe Mental Illnesses
Torrey, W. C., Drake, R. E., Dixon, L., Burns, B. J., Flynn, L., Rush, A. J., Clark, R. E., & Klatzker, D. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.1.45 · Cited by 491
Amplitude of low-frequency oscillations in schizophrenia: A resting state fMRI study
Hoptman, M. J., Zuo, X.-N., Butler, P. D., Javitt, D. C., D'Angelo, D., Mauro, C. J., & Milham, M. P. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.09.030 · Cited by 462
Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A., Thompson, J., & Zito, J. M. (1998) · JAMA · doi:10.1001/jama.279.7.526 · Cited by 423
Dextromethorphan decreases the excitability of the human motor cortex
Ziemann, U., Chen, R., Cohen, L. G., & Hallett, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1320 · Cited by 422
Seal, K. H., Maguen, S., Cohen, B., Gima, K. S., Metzler, T. J., Ren, L., Bertenthal, D., & Marmar, C. R. (2010) · Journal of Traumatic Stress · doi:10.1002/jts.20493 · Cited by 422
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Dementia care: mental health effects, intervention strategies, and clinical implications
Sörensen, S., Duberstein, P., Gill, D., & Pinquart, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70599-3 · Cited by 396
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
Correll, C. U., Rummel-Kluge, C., Corves, C., Kane, J. M., & Leucht, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn018 · Cited by 397
Depression in Alzheimer’s disease: overview and treatment
Lyketsos, C. G., & Olin, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01348-3 · Cited by 394
Tiihonen, J., Walhbeck, K., Lönnqvist, J., Klaukka, T., Ioannidis, J. P. A., Volavka, J., & Haukka, J. (2006) · BMJ · doi:10.1136/bmj.38881.382755.2f · Cited by 385
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
Jann, M. W., Shirley, K. L., & Small, G. W. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241100-00003 · Cited by 365
Olanzapine versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel-Kluge, C., Hunger, H., Schmid, F., Schwarz, S., Duggan, L., Kissling, W., & Leucht, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006654.pub2 · Cited by 365
Psychoeducation as Evidence-Based Practice: Considerations for Practice, Research, and Policy
Lukens, E. P., & McFarlane, W. R. (2004) · Brief Treatment and Crisis Intervention · doi:10.1093/brief-treatment/mhh019 · Cited by 361
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
McClellan, J., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.008 · Cited by 361
Dose Response and Dose Equivalence of Antipsychotics
Davis, J. M., & Chen, N. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117422.05703.ae · Cited by 358
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Peuskens, J., Pani, L., Detraux, J., & De Hert, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0157-3 · Cited by 350
Lieberman, J. A., Phillips, M., Gu, H., Stroup, S., Zhang, P., Kong, L., Ji, Z., Koch, G., & Hamer, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300157 · Cited by 345
Pharmacy Data Identify Poorly Adherent Patients With Schizophrenia at Increased Risk for Admission
Valenstein, M., Copeland, L. A., Blow, F. C., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2002) · Medical Care · doi:10.1097/00005650-200208000-00002 · Cited by 338
A conceptual framework for drug treatment process and outcomes
Simpson, D. D. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.06.001 · Cited by 332
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guide, Falkai, P., Wobrock, T., Lieberman, J., et al. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970500483177 · Cited by 331
PILLING, S., BEBBINGTON, P., KUIPERS, E., GARETY, P., GEDDES, J., MARTINDALE, B., ORBACH, G., & MORGAN, C. (2002) · Psychological Medicine · doi:10.1017/s0033291702005640 · Cited by 321
Recent Developments in Family Psychoeducation as an Evidence‐Based Practice
Lucksted, A., McFarlane, W., Downing, D., & Dixon, L. (2012) · Journal of Marital and Family Therapy · doi:10.1111/j.1752-0606.2011.00256.x · Cited by 316
Mishara, A. L., & Goldberg, T. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.027 · Cited by 310
Measurement of Fidelity in Psychiatric Rehabilitation
Bond, G. R., Evans, L., Salyers, M. P., Williams, J., & Kim, H.-W. (2000) · Mental Health Services Research · doi:10.1023/a:1010153020697 · Cited by 302
Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients
Toyooka, K., Asama, K., Watanabe, Y., Muratake, T., Takahashi, M., Someya, T., & Nawa, H. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00127-0 · Cited by 292
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
PAPPADOPULOS, E., MACINTYRE, J. C., CRISMON, M. L., FINDLING, R. L., MALONE, R. P., DERIVAN, A., SCHOOLER, N., SIKICH, L., GREENHILL, L., SCHUR, S. B., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00008 · Cited by 289
Singh, J. P., Desmarais, S. L., Hurducas, C., Arbach-Lucioni, K., Condemarin, C., Dean, K., Doyle, M., Folino, J. O., Godoy-Cervera, V., Grann, M., et al. (2014) · International Journal of Forensic Mental Health · doi:10.1080/14999013.2014.922141 · Cited by 278
Lyketsos, C. G., Colenda, C. C., Beck, C., Blank, K., Doraiswamy, M. P., Kalunian, D. A., & Yaffe, K. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000221334.65330.55 · Cited by 275
A history of antipsychotic drug development
Shen, W. W. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90082-2 · Cited by 273
Poor Antipsychotic Adherence Among Patients With Schizophrenia: Medication and Patient Factors
Valenstein, M., Blow, F. C., Copeland, L. A., McCarthy, J. F., Zeber, J. E., Gillon, L., Bingham, C. R., & Stavenger, T. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007076 · Cited by 273
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270
Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Möller, H.-J., WFSBP Task Force on Treatment Guidelines for Schizophrenia, Falkai, P., Wobrock, T., Lieberman, J., et al. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510030090 · Cited by 269
Depressive Symptomatology and Incident Cognitive Decline in an Elderly Community Sample
Bassuk, S. S., Berkman, L. F., & Wypij, D. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1073 · Cited by 263
Processing Speed Deficits in Schizophrenia: Reexamining the Evidence
Knowles, E. E. M., David, A. S., & Reichenberg, A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09070937 · Cited by 261
A Program for Relapse Prevention in Schizophrenia: A Controlled Study
Herz, M. I., Lamberti, J. S., Mintz, J., Scott, R., O'Dell, S. P., McCartan, L., & Nix, G. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.277 · Cited by 260
Quetiapine versus other atypical antipsychotics for schizophrenia
Komossa, K., Rummel-Kluge, C., Schmid, F., Hunger, H., Schwarz, S., Srisurapanont, M., Kissling, W., & Leucht, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006625.pub2 · Cited by 260
Corson, P. W., Nopoulos, P., Miller, D. D., Arndt, S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1200 · Cited by 254
Research on psychotherapy efficacy and effectiveness: Between Scylla and Charybdis?
Nathan, P. E., Stuart, S. P., & Dolan, S. L. (2000) · Psychological Bulletin · doi:10.1037/0033-2909.126.6.964 · Cited by 258
Nasrallah, H., Morosini, P., & Gagnon, D. D. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.11.012 · Cited by 243
Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For The Treatment Of Schizophrenia And Related Disorders (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01516.x · Cited by 435
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226
Correll, C. U., Kim, E., Sliwa, J. K., Hamm, W., Gopal, S., Mathews, M., Venkatasubramanian, R., & Saklad, S. R. (2021) · CNS Drugs · doi:10.1007/s40263-020-00779-5 · Cited by 205
“Antipsychotic medications are a fundamental element of treatment used to reduce intensity and frequency of symptoms [3].”
Fazel, S., Lichtenstein, P., Grann, M., & Långström, N. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001150 · Cited by 181
Sexual dysfunction and antipsychotic treatment
Cutler, A. J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00113-0 · Cited by 176
Snowden, M., Sato, K., & Roy‐Byrne, P. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51417.x · Cited by 171
Chen, E. Y. H., Hui, C. L. M., Lam, M. M. L., Chiu, C. P. Y., Law, C. W., Chung, D. W. S., Tso, S., Pang, E. P. F., Chan, K. T., Wong, Y. C., et al. (2010) · BMJ · doi:10.1136/bmj.c4024 · Cited by 151
Aripiprazole versus other atypical antipsychotics for schizophrenia
Khanna, P., Suo, T., Komossa, K., Ma, H., Rummel-Kluge, C., El-Sayeh, H. G., Leucht, S., & Xia, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006569.pub5 · Cited by 151
Torrens, M., Rossi, P. C., Martinez-Riera, R., Martinez-Sanvisens, D., & Bulbena, A. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.663296 · Cited by 122
Emotional responding in deficit and non-deficit schizophrenia
Earnst, K. S., & Kring, A. M. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00083-9 · Cited by 124
Chien, W. T., & Thompson, D. R. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.134635 · Cited by 115
Sudden unexpected death in schizophrenia: Autopsy findings in psychiatric inpatients
Ifteni, P., Correll, C. U., Burtea, V., Kane, J. M., & Manu, P. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.011 · Cited by 91
Packages of Care for Schizophrenia in Low- and Middle-Income Countries
Mari, J. D. J., Razzouk, D., Thara, R., Eaton, J., & Thornicroft, G. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000165 · Cited by 91
Premorbid Functioning in Early-Onset Psychotic Disorders
MCCLELLAN, J., BREIGER, D., MCCURRY, C., & HLASTALA, S. A. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046844.56865.6b · Cited by 90
What causes problems in Alzheimer's disease: attributions by caregivers. A qualitative study
Paton, J., Johnston, K., Katona, C., & Livingston, G. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1118 · Cited by 82
Warning signs for suicide within a week of healthcare contact in Veteran decedents
Britton, P. C., Ilgen, M. A., Rudd, M. D., & Conner, K. R. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.06.036 · Cited by 75
Knegtering, H., Boks, M., Blijd, C., Castelein, S., van den Bosch, R. J., & Wiersma, D. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600666378 · Cited by 74
Brown, A. H., Cohen, A. N., Chinman, M. J., Kessler, C., & Young, A. S. (2008) · Implementation Science · doi:10.1186/1748-5908-3-9 · Cited by 53
Mortality from treatable illnesses in marginally housed adults: a prospective cohort study
Jones, A. A., Vila-Rodriguez, F., Leonova, O., Langheimer, V., Lang, D. J., Barr, A. M., Procyshyn, R. M., Smith, G. N., Schultz, K., Buchanan, T., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008876 · Cited by 40
Boonstra, G., Burger, H., Grobbee, D. E., & Kahn, R. S. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.534801 · Cited by 38
Fujiwara, H., Shimizu, M., Hirao, K., Miyata, J., Namiki, C., Sawamoto, N., Fukuyama, H., Hayashi, T., & Murai, T. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.013 · Cited by 36
Tool-use Extends Peripersonal Space Boundaries in Schizophrenic Patients
Ferroni, F., Ardizzi, M., Magnani, F., Ferri, F., Langiulli, N., Rastelli, F., Lucarini, V., Giustozzi, F., Volpe, R., Marchesi, C., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac067 · Cited by 32
Landolt, K., Rössler, W., Ajdacic-Gross, V., Derks, E. M., Libiger, J., Kahn, R. S., & Fleischhacker, W. W. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.046 · Cited by 28
Rouillon, F., Chartier, F., & Gasquet, I. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.012 · Cited by 23
Rabovsky, K., Trombini, M., Allemann, D., & Stoppe, G. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0291-1 · Cited by 20
Lavaud, P., McMahon, K., Sánchez Rico, M., Hanon, C., Alvarado, J. M., de Raykeer, R. P., Limosin, F., & Hoertel, N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2021.114339 · Cited by 16
War-related somatoform disorder in an older adult veteran
Jacobs, L., & Dinoff, B. (2012) · Clinical Case Studies · doi:10.1177/1534650112461848 · Cited by 8
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-04-01
- Volume
- 154
- Issue
- 4
- Pages
- 1-63
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2607257274
- Cited by
- 1,348
- References
- 6
- FWCI
- 49.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.